Elliott, Paul http://orcid.org/0000-0002-7511-5684
Eales, Oliver
Bodinier, Barbara http://orcid.org/0000-0002-0781-3624
Tang, David http://orcid.org/0000-0002-6974-5663
Wang, Haowei
Jonnerby, Jakob
Haw, David
Elliott, Joshua
Whitaker, Matthew http://orcid.org/0000-0003-1363-6537
Walters, Caroline E.
Atchison, Christina http://orcid.org/0000-0001-8304-7389
Diggle, Peter J.
Page, Andrew J. http://orcid.org/0000-0001-6919-6062
Trotter, Alexander J.
Ashby, Deborah http://orcid.org/0000-0003-3146-7466
Barclay, Wendy http://orcid.org/0000-0002-3948-0895
Taylor, Graham http://orcid.org/0000-0002-3773-2390
Ward, Helen http://orcid.org/0000-0001-8238-5036
Darzi, Ara http://orcid.org/0000-0001-7815-7989
Cooke, Graham S. http://orcid.org/0000-0001-6475-5056
Chadeau-Hyam, Marc http://orcid.org/0000-0001-8341-5436
Donnelly, Christl A. http://orcid.org/0000-0002-0195-2463
Funding for this research was provided by:
Department of Health and Social Care in England
Cancer Research UK (22184)
EC | Horizon 2020 Framework Programme (874627, 874739)
Article History
Received: 19 February 2022
Accepted: 18 July 2022
First Online: 3 August 2022
Competing interests
: AD is chairman of the Health Security and Pre-Emptive Medicine Initiative, Flagship Pioneering UK plc and has no conflict of interest to declare. MC-H holds shares in the O-SMOSE company. Consulting activities conducted by the company are independent of the present work and MC-H has no conflict of interest to declare. All other authors have no competing interests to declare.